Header Logo

Connection

JOHN VIERLING to Immunophenotyping

Back to Details
This is a "connection" page, showing publications JOHN VIERLING has written about Immunophenotyping.
JOHN VIERLING
Connection Strength
0.019
Immunophenotyping
  1. Biochemical and immunologic effects of rituximab in patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid. Hepatology. 2012 Feb; 55(2):512-21.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.